Today in its company sponsored RegMedNet post, Asymmetrex highlights how its AlphaSTEM technology for counting adult tissue stem cells has potential for high impact in the pharmaceutical industry. Regenerative medicine also encompasses the application of stem cell fundamentals to identify traditional small molecules and biologics drug candidates to treat disorders of aging, induce or accelerate
Asymmetrex Ready to Do a Number for Hematopoietic Stem Cell Transplantation Therapies To prepare the field of regenerative medicine for its AlphaSTEM stem cell counting technology, Asymmetrex makes good on its earlier promise to post on the RegMedNet Industry Developments page an expose on the vexing, but silent, nature of the HSC counting problem in HSCT
Cliches abound to describe the “unique” properties of adult tissue stem cells. The lay publications of the National Institutes of Health are full of them. “Self-renew.” “Differentiate.” “Multipotent.” The problem with lazy cliches is that they often understate and distort the calming and terrifying beauty of life. The life of adult stem cells is no
With its recently described improved technologies for specifically identifying adult tissue stem cells or detecting their function by a computer simulation technology, biotech start-up Asymmetrex is anticipating a need for rules to move the field of stem cell biology from a past of common errors and misconceptions to a future of exact quantification. Asymmetrex’s 5
As ideas on the potential ability of some adult tissue stem cells to accelerate repair of damaged or injured tissues have grown to be more widely disseminated, so has interest grown in developing stem cell treatments within standard medical practice. In particular, chronic debilitating ailments like joint pain and low back pain, caused either by
With the tsunami of research on pluripotent stem cells induced by a 2012 Nobel Prize, in the past several years, adult tissue stem cells experienced a major loss of interest and research effort. Yet, the greatest progress in stem cell medicine is still due to, in some cases well-known and in other cases not so
Ad Hoc Stem Cell Medical Research? Eight General Principles For Its Advance Stem cell medicine has a new rapidly moving frontier of research and treatment activity. To help keep that frontier from getting too wild, stem cellbiologist and physician scientist James Sherley recently teamed up with Boston Biolife to provide continuing stem cell medical education
Adult tissue stem cells have a growing list of current and potential medical applications, including drug development; gene therapy; bone marrow or corneal restoration; treatments for low back pain and other degenerative joint diseases; treatments for heart attack and stroke; treatment for chronic illnesses like multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS); treatment for
Since the beginnings of the field of stem cell biology, more than half a century ago, it has not been possible to count adult tissue stem cells in experimental and clinical preparations. This surprising, but widely known, situation exists because, although tissue stem cells are unique in function from all other tissue cells, they do
With Disclosure of Recently Met Benchmarks for Its Adult Tissue Stem Cell Counting Technology, Asymmetrex Targets Applications to Enable Gene-Editing Therapies Yesterday, tissue stem cell biotechnology start-up company Asymmetrex, LLC posted results on its website from the most recently completed benchmark studies for its computer simulation technology for determining the number of stem cells in